An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease

Share this content:
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease

Sponsors and Collaborators
Genzyme

Contact
Medical Information
800-745-4447
medinfo@genzyme.com

Medical Information
617-252-7832
medinfo@genzyme.com

Principal Investigator
Medical Monitor, Genzyme

ClinicalTrials.gov Identifier
NCT01574326

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters